Filing Details

Accession Number:
0001209191-16-151190
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-18 16:05:18
Reporting Period:
2016-11-16
Filing Date:
2016-11-18
Accepted Time:
2016-11-18 16:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585005 J. Steven Kafka 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-16 1,000 $4.16 102,550 No 4 M Direct
Common Stock Disposition 2016-11-16 1,000 $23.00 101,550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2016-11-16 1,000 $0.00 1,000 $4.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,168 2023-03-07 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2016.
  2. This is a non-qualified portion of an option granted on March 7, 2013 that vested 25% on January 2, 2014 and then vests in equal quarterly installments until fully vested on January 2, 2017.